Published in PLoS One on December 29, 2014
Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa. PLoS Negl Trop Dis (2015) 1.72
Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors (2015) 1.14
Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasit Vectors (2015) 1.01
Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings. Parasit Vectors (2016) 0.97
The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data. Parasit Vectors (2015) 0.90
Feasibility of controlling hookworm infection through preventive chemotherapy: a simulation study using the individual-based WORMSIM modelling framework. Parasit Vectors (2015) 0.90
Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results. Infect Dis Poverty (2016) 0.88
Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal. Epidemics (2017) 0.85
Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes. PLoS Negl Trop Dis (2017) 0.84
Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme. PLoS Negl Trop Dis (2015) 0.83
Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models. Parasit Vectors (2016) 0.80
Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness? Clin Infect Dis (2016) 0.80
Comparison of Doxycycline, Minocycline, Doxycycline plus Albendazole and Albendazole Alone in Their Efficacy against Onchocerciasis in a Randomized, Open-Label, Pilot Trial. PLoS Negl Trop Dis (2017) 0.77
Research for new drugs for elimination of onchocerciasis in Africa. Int J Parasitol Drugs Drug Resist (2016) 0.77
Monitoring the efficacy of drugs for neglected tropical diseases controlled by preventive chemotherapy. J Glob Antimicrob Resist (2015) 0.76
Measuring and modelling the effects of systematic non-adherence to mass drug administration. Epidemics (2017) 0.75
Assessment of the scope and practice of evaluation among medical donation programs. Global Health (2016) 0.75
Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity. PLoS Negl Trop Dis (2017) 0.75
Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet (2002) 7.25
Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis (2009) 4.05
Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis (2012) 2.42
Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors (2012) 2.08
Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ (2002) 1.99
Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis (2008) 1.88
The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol (2008) 1.79
The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop (1991) 1.76
Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy. Acta Trop (2010) 1.70
ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed (1990) 1.70
Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis (2011) 1.67
Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 1.67
The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol (2008) 1.62
African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost. PLoS Negl Trop Dis (2013) 1.61
Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis (1995) 1.58
Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am J Trop Med Hyg (2005) 1.49
Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. Int J Parasitol (2011) 1.25
The risk and dynamics of onchocerciasis recrudescence after cessation of vector control. Bull World Health Organ (1991) 1.24
The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg (1995) 1.21
Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology (2008) 1.18
Integrated community-directed intervention for schistosomiasis and soil transmitted helminths in western Kenya - a pilot study. Parasit Vectors (2012) 1.17
Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. PLoS Negl Trop Dis (2013) 1.13
The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America. Am J Trop Med Hyg (2004) 1.12
Implementing preventive chemotherapy through an integrated National Neglected Tropical Disease Control Program in Mali. PLoS Negl Trop Dis (2012) 1.09
The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study. PLoS Negl Trop Dis (2013) 1.09
Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis. PLoS Negl Trop Dis (2013) 1.08
Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv Parasitol (2009) 1.07
Programme activities: a major burden for district health systems? Trop Med Int Health (2008) 1.07
Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms. Parasitology (2005) 1.06
Density dependence and overdispersion in the transmission of helminth parasites. Parasitology (2005) 1.05
Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg (1991) 1.03
Density-dependent processes in the transmission of human onchocerciasis: relationship between the numbers of microfilariae ingested and successful larval development in the simuliid vector. Parasitology (1995) 1.03
How long do the effects of ivermectin on adult Onchocerca volvulus persist? Trop Med Parasitol (1993) 1.03
Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae. PLoS Negl Trop Dis (2013) 1.02
Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. Bull World Health Organ (1997) 1.02
Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin. Trop Med Int Health (1996) 1.00
Effects of three-month doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg (1992) 0.99
Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg (1990) 0.99
Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon. PLoS Negl Trop Dis (2013) 0.96
Uptake of Onchocerca volvulus (Nematoda: Onchocercidae) by Simulium (Diptera: Simuliidae) is not strongly dependent on the density of skin microfilariae in the human host. J Med Entomol (2004) 0.95
The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis. Int J Parasitol (2004) 0.89
Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin. Trop Med Parasitol (1993) 0.88
Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment. Int J Parasitol Drugs Drug Resist (2012) 0.88
Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin. Bull World Health Organ (1991) 0.87
Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon. PLoS Negl Trop Dis (2014) 0.83
African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2013. Wkly Epidemiol Rec (2013) 0.81